About four hundred complaints were received by the United States Food and Drugs Administration regarding the apparent adverse effects DePuy's ASR XL Acetabular System and ASR Hip Resurfacing System inflicts upon recipients resulting in the hip replacement recall. A series of studies conducted by foreign joint registries then prompted DePuy Orthopaedics to recall their products. Now, it would seem that the FDA is taking independent action to address adverse event reports that they have receiv...


Continue reading ...